Package 53746-751-05

Brand: benazepril hydrochloride

Generic: benazepril hydrochloride
NDC Package

Package Facts

Identity

Package NDC 53746-751-05
Digits Only 5374675105
Product NDC 53746-751
Description

500 TABLET in 1 BOTTLE (53746-751-05)

Marketing

Marketing Status
Marketed Since 2022-09-26
Brand benazepril hydrochloride
Generic benazepril hydrochloride
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "e8e7c1c3-9bd1-4752-9ad9-da0a73c12a0a", "openfda": {"upc": ["0353746751010", "0353746754011", "0353746753014"], "unii": ["N1SN99T69T"], "rxcui": ["898687", "898690", "898719", "898723"], "spl_set_id": ["e0ddcfbc-c9d8-45b1-9c11-0d1eff8c1e9e"], "manufacturer_name": ["Amneal Pharmaceuticals of New York LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET in 1 BOTTLE (53746-751-01)", "package_ndc": "53746-751-01", "marketing_start_date": "20220926"}, {"sample": false, "description": "500 TABLET in 1 BOTTLE (53746-751-05)", "package_ndc": "53746-751-05", "marketing_start_date": "20220926"}], "brand_name": "Benazepril Hydrochloride", "product_id": "53746-751_e8e7c1c3-9bd1-4752-9ad9-da0a73c12a0a", "dosage_form": "TABLET", "pharm_class": ["Angiotensin Converting Enzyme Inhibitor [EPC]", "Angiotensin-converting Enzyme Inhibitors [MoA]", "Decreased Blood Pressure [PE]"], "product_ndc": "53746-751", "generic_name": "Benazepril Hydrochloride", "labeler_name": "Amneal Pharmaceuticals of New York LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Benazepril Hydrochloride", "active_ingredients": [{"name": "BENAZEPRIL HYDROCHLORIDE", "strength": "5 mg/1"}], "application_number": "ANDA076820", "marketing_category": "ANDA", "marketing_start_date": "20220926", "listing_expiration_date": "20271231"}